» NeuroPhage to Participate on Neuroscience Drug Development Panel at MassBio Annual Meeting March 27, 2015

CAMBRIDGE, Mass., March 20, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Jonathan Solomon, CEO, will participate on an expert panel, "Neuroscience Therapeutics Development: Challenges, Opportunities and the Road Ahead," at the Massachusetts...

» Fattah Statement on Brain Awareness Week

WASHINGTON, March 18, 2015 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (PA-02), a Senior Member on the House Appropriations Committee and lead Democrat on the Subcommittee on Commerce, Justice, and Science (CJS) released the following statement recognizing Brain Awareness Week,...

» America's Aging Population Will Require More Neurosurgeons To Handle Increased Brain Bleeds
NEW YORK, March 19, 2015 /PRNewswire-USNewswire/ -- By 2030, chronic subdural hemorrhage (SDH) will be the most common adult brain condition requiring neurosurgical intervention in the U.S., according to a new study conducted by researchers at NYU Langone Medical Center. And hospitals and...